摘要
目的探讨复方参芪维E胶囊联合泛昔洛韦对带状疱疹患者免疫功能的影响。方法将124例患者随机分为两组,各62例。对照组患者应用泛昔洛韦治疗,同时肌肉注射干扰素α-2b,持续用药7 d;观察组开始用药同对照组,停药后口服复方参芪维E胶囊,持续用药10 d。对比分析两组患者临床疗效及症状缓解时间,治疗前后应用流式细胞仪测定两组T淋巴细胞亚群。结果观察组总有效率为93.55%,明显高于对照组的77.42%(P<0.05)。观察组止疱、结痂、疼痛缓解、脱痂时间均明显短于对照组(P<0.05)。观察组治疗后CD+3,CD4+,CD4+/CD+8水平显著高于对照组,而CD+8水平则低于对照组(P<0.05)。观察组后遗神经痛发生率为0(0/62),低于对照组的8.06%(5/62),两组比较有统计学差异(P<0.05)。结论复方参芪维E胶囊联合泛昔洛韦治疗带状疱疹,能有效提高疗效,缓解临床症状,且能有效预防后遗神经痛的发生,同时可提高患者的免疫功能。
Objective To investigate the effect of Compound Shenqi Vitamin E Capsules combined with famciclovir on the immune function in the patients with herpes zoster. Methods 124 cases of herpes zoster were randomly divided into the observation group( n = 62) and the control group( n =62). The control group simuhaneously applied famcielovir and intramuscular injection of interferon for continuous 7 d; while at the beginning the medication in the observation group was same to the control group, after drug withdrawal oral Compound Shenqi Vitamin E Capsules was given for continuous 10 d. The clinical effects and the symptom remission time were compared between the two groups. The levels of CD2 T lymphocyte subsets before and after treatment in the two groups were detected by the flow cytometry. Results The total effective rate of observation group was 93.55% ,which was higher than 77.42% in the control group,the difference had statistical significance(P 〈 0.05). The time of blister stop,crusting time,pain relief time and decrustation time in the observation group were shorter than those in the control group(P 〈 0. 05). The levels of CD;,CD4+ and CD4+/CD8+ in the ob- servation group were significantly higher than those in the control group,while the level of CD8+ was lower than that in the control group (P 〈 0. 05). The incidence rate of postherpetic neuralgia in observation group was 0. 00% (0/62),which was lower than 8.06% (5/62) in the control group,there was statistically significant difference between the two groups(P 〈 0. 05). Conclusion Compound Shenqi Vtamin E Capsule combined with famciclovir in treating herpes zoster can improve the curative effect, alleviate the clinical symptoms,effectively prevent the occurrence of postherpetic neuralgia and simultaneously increase the patient's immune function.
出处
《中国药业》
CAS
2014年第16期32-33,共2页
China Pharmaceuticals
基金
江西省科技厅科技支撑计划项目
项目编号:20133BBE50015